0.86 USD
↘ 0.01 (0.67%)AT CLOSE (11:59 AM EDT)
Oncolytics Biotech, Inc. Common Shares
ONCYNASDAQ • USD
0.86
↘ 0.00 (0.07%)
POST MARKET (AS OF 08:00 PM EDT)
Post Market
AS OF 08:00 PM EDT
0.86
↘ 0.00 (0.07%)
Market: CLOSED
Shares of Oncolytics Biotech, Inc. Common Shares (ONCY) are trading at $0.86. There is a divergence between signals — technical indicators rate "Buy" but underlying fundamentals lean "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation metrics place ONCY at a fair price relative to peers.
Technical & fundamental data as of Aug 26, 2026.
Open?$0.86
High?$0.87
Low?$0.84
Prev. Close?$0.86
Volume?410.9K
Avg. Volume?881.1K
VWAP?$0.85
Rel. Volume?0.47x
Bid / Ask
Bid?$0.84 × 200
Ask?$0.87 × 900
Spread?$0.03
Midpoint?$0.86
Valuation & Ratios
Market Cap?109.7M
Shares Out?127.5M
Float?112.0M
Float %?96.4%
P/E Ratio?N/A
P/B Ratio?5.36
EPS?-$0.11
Dividend?4.22%
Ex-Dividend?N/A
News
Profile
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.
Employees
29
Market Cap
109.8M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2001-10-05
Address
SUITE 325, 4350 EXECUTIVE DRIVE
SAN DIEGO, CA 92121
Phone: (403) 670-7377
SAN DIEGO, CA 92121
Phone: (403) 670-7377
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?48
Piotroski F-Score?0/9Weak
Altman Z-Score?-88.94Distress
Confidence?51%Low
Short InterestVery High
Short % of Float?7.56%Elevated
Short Interest?8.5M
Days to Cover?12.7
Free Float112.0M
Avg Daily Volume669.0K
Settlement Date2026-08-14
Financial Health
Current Ratio?8.85Strong
Quick Ratio?8.85Strong
Cash Ratio?7.92Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?5.36FAIR▾
Peers100
S&P35
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-6.3CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-69.3%WEAK▾
S&P3
ROA?-61.6%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-15407212
Enterprise Value?$89.4M
Fundamentals ratios updated end of day